Skip to main content
logo
Pharmagreen Biotech Inc. (PHBI)
OTCMKTS · Delayed Price · Currency is USD
0.0019
+0.0001 (5.56%)
Oct 27, 2025, 3:50 PM EDT

Pharmagreen Biotech Revenue

Pharmagreen Biotech had revenue of $828.00 in the quarter ending December 31, 2024, a decrease of -33.01%. This brings the company's revenue in the last twelve months to $3.00K, down -29.10% year-over-year. In the fiscal year ending September 30, 2024, Pharmagreen Biotech had annual revenue of $3.41K with 13.74% growth.

Revenue (ttm)
3.00K
Revenue Growth
-29.10%
P/S Ratio
420.03
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.26M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 20243.41K412.0013.74%
Sep 30, 20233.00K--
Sep 30, 2022---
Sep 30, 2021---
Sep 30, 2020---
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Jushi Holdings256.36M
Glass House Brands221.55M
Elite Pharmaceuticals105.45M
Silence Therapeutics27.17M
Nuo Therapeutics1.95M
Northwest Biotherapeutics1.09M
Revenue Rankings

Pharmagreen Biotech News

More News